Skip to main content
. 2019 Sep 26;14:2205–2217. doi: 10.2147/COPD.S213947

Figure 3.

Figure 3

Treatment details for all patients (available data): short-acting beta-agonists (SABA, n=374), long-acting muscarinic antagonists (LAMA, n=373), long-acting beta-agonists (LABA, n=373), inhaled corticosteroids (ICS, n=372), antibiotic prophylaxis (AP, n=374) and long-term oxygen therapy (LTOT, n=375).